Pregnancy outcomes in ANCA-associated vasculitis patients: A systematic review and meta-analysis

被引:4
|
作者
Partalidou, Styliani [1 ]
Mamopoulos, Apostolos [2 ]
Dimopoulou, Despoina [1 ]
Sarafidis, Pantelis [3 ]
Dimitroulas, Theodoros [1 ]
机构
[1] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Sch Med, Dept Internal Med 4, Thessaloniki 54642, Greece
[2] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Sch Med, Dept Obstet & Gynecol 3, Thessaloniki 54642, Greece
[3] Aristotle Univ Thessaloniki, Hippokrat Hosp, Sch Med, Dept Nephrol, Thessaloniki 54642, Greece
关键词
Granulomatosis with polyangiitis; Eosinophilic granulomatosis with polyangiitis; Microscopic polyangiitis; Systemic vasculitides; ANCA-associated vasculitis; Pregnancy outcomes; WEGENERS-GRANULOMATOSIS; WOMEN;
D O I
10.1016/j.jbspin.2023.105609
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV), namely granulo-matosis with polyangiitis, eosinophilic granulomatosis with polyangiitis and microscopic polyangiitis constitute a group of rare systemic vasculitides, affecting small vessels. Genders are equally affected, with symptoms most commonly presenting during and/or after the fifth decade of life, but AAV may also present in younger individuals. As advanced maternal age is becoming common and safe over the last decades, it is now more feasible for middle-aged women suffering from AAV to get pregnant. Although adverse pregnancy outcomes have been thoroughly investigated in other systemic diseases, the exact prevalence of pregnancy complications and unfavorable outcomes in pregnant women with AAV has not been systematically evaluated.Methods: We researched PubMed, Scopus, Cochrane Library and Cinahl databases until September, 2022. Three blinded investigators extracted data and assessed the risk of bias. A random effects model was used for the analysis. The outcomes studied were pre-term delivery, intrauterine growth restriction (IUGR) neonates and disease flare.Results: We included six studies with 92 pregnancies in patients with AAV. The prevalence of pre-term delivery, IUGR neonates and disease flare were 18% (CI: 0.10-0.30,P= non-significant), 20% (CI: 0.11-0.33, P= non-significant) and 28% (CI: 0.09-0.59, P< 0.01), respectively.Conclusion: The analysis demonstrated higher occurrence of adverse outcomes in pregnant women suf-fering from AAV accompanied by an increased risk of disease flare during pregnancy. These findings underline the importance of preconception counseling and the necessity of close monitoring in these patients similarly to other systemic inflammatory diseases.& COPY; 2023 Socie & PRIME;te & PRIME; franc, aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy-A meta-analysis
    Pope, Victor
    Sivashanmugathas, Varunaavee
    Moodley, Dirusha
    Gunaratnam, Lakshman
    Barra, Lillian
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 60
  • [42] Pharmacokinetics of Rituximab and Clinical Outcomes in Patients with ANCA-Associated Vasculitis
    Cornec, Divi
    Kabat, Brian
    Mills, John
    Cheu, Melissa
    Hummel, Amber
    Schroeder, Darrell
    Cascino, Matthew
    Brunetta, Paul
    Murray, David
    Snyder, Melissa
    Fervenza, Fernando
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Langford, Carol A.
    Merkel, Peter A.
    Monach, Paul A.
    Seo, Philip
    Spiera, Robert F.
    St Clair, E. William
    Stone, John H.
    Barnidge, David
    Specks, Ulrich
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [43] Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-a meta-analysis
    Tomasson, Gunnar
    Grayson, Peter C.
    Mahr, Alfred D.
    LaValley, Michael
    Merkel, Peter A.
    RHEUMATOLOGY, 2012, 51 (01) : 100 - 109
  • [44] Characteristics and outcomes of patients with ANCA-associated vasculitis in the Czech population
    Hruskova, Z.
    Jancova, E.
    Lanska, V.
    Svojanovsky, J.
    Klaboch, J.
    Nemec, P.
    Zamboch, K.
    Kodeda, M.
    Hanzal, V.
    Nemejc, P.
    Tesar, V.
    PRESSE MEDICALE, 2013, 42 (04): : 664 - 665
  • [45] Avacopan for Patients with ANCA-associated Vasculitis
    Rauen, Thomas
    Kraemer, Stefan
    Floege, Juergen
    NEPHROLOGIE, 2022, 17 (02): : 117 - 118
  • [46] Management of ANCA-Associated Vasculitis in Pregnancy Case Report and Review of the Literature
    Raza, Syed Hasan
    Sabghi, Roxanna
    Kuperman, Micahel
    Postlethwaite, Bradley
    Pattanaik, Debendra
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (04) : E146 - E149
  • [47] ANCA-ASSOCIATED VASCULITIS IN PATIENTS WITH SLE
    Ziauddin, O.
    Levine, J.
    Cedillo-Couvert, E.
    Setty, S.
    Arami, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (04) : 873 - 874
  • [48] Morbidity in patients with ANCA-associated vasculitis
    Harper, Lorraine
    PRESSE MEDICALE, 2013, 42 (04): : 612 - 616
  • [49] INCIDENCE AND RISK FACTORS OF VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS: A META-ANALYSIS AND METAREGRESSION
    Hansrivijit, Panupong
    Trongtorsak, Angkawipa
    Gadhiya, Kinjal
    Lnu, Kriti
    Dimech, Christina
    Thongprayoon, Charat
    Cheungpasitporn, Wisit
    Lecker, Stewert
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 602 - 602
  • [50] ANCA-associated vasculitis
    Herrera-Darias, Sandro
    Guillen-Chirinos, Gilsy
    Gomez-Cerquera, Juan Manuel
    MEDICINA CLINICA, 2023, 160 (10): : 467 - 467